these findings suggest that future strategies for aids prevention in high-risk groups should include institution of large controlled trials in immunodeficient , asymptomatic , htlv-iii/lav-seronegative male homosexuals to study the potential of selective immunoreconstitution as a preventive measure against htlv-iii/lav infection .
C0021051
immunodeficient
C0019693
htlv-iii/lav infection